194 related articles for article (PubMed ID: 35357488)
1. hnRNP G/RBMX enhances HPV16 E2 mRNA splicing through a novel splicing enhancer and inhibits production of spliced E7 oncogene mRNAs.
Hao C; Zheng Y; Jönsson J; Cui X; Yu H; Wu C; Kajitani N; Schwartz S
Nucleic Acids Res; 2022 Apr; 50(7):3867-3891. PubMed ID: 35357488
[TBL] [Abstract][Full Text] [Related]
2. Heterogeneous Nuclear Ribonucleoprotein A1 (hnRNP A1) and hnRNP A2 Inhibit Splicing to Human Papillomavirus 16 Splice Site SA409 through a UAG-Containing Sequence in the E7 Coding Region.
Zheng Y; Jönsson J; Hao C; Shoja Chaghervand S; Cui X; Kajitani N; Gong L; Wu C; Schwartz S
J Virol; 2020 Sep; 94(20):. PubMed ID: 32759322
[TBL] [Abstract][Full Text] [Related]
3. A novel HPV16 splicing enhancer critical for viral oncogene expression and cell immortalization.
Jönsson J; Wang L; Kajitani N; Schwartz S
Nucleic Acids Res; 2024 Jan; 52(1):316-336. PubMed ID: 37994701
[TBL] [Abstract][Full Text] [Related]
4. HnRNP D activates production of HPV16 E1 and E6 mRNAs by promoting intron retention.
Cui X; Hao C; Gong L; Kajitani N; Schwartz S
Nucleic Acids Res; 2022 Mar; 50(5):2782-2806. PubMed ID: 35234917
[TBL] [Abstract][Full Text] [Related]
5. Intron definition and a branch site adenosine at nt 385 control RNA splicing of HPV16 E6*I and E7 expression.
Ajiro M; Jia R; Zhang L; Liu X; Zheng ZM
PLoS One; 2012; 7(10):e46412. PubMed ID: 23056301
[TBL] [Abstract][Full Text] [Related]
6. Efficient production of HPV16 E2 protein from HPV16 late mRNAs spliced from SD880 to SA2709.
Zheng Y; Cui X; Nilsson K; Yu H; Gong L; Wu C; Schwartz S
Virus Res; 2020 Aug; 285():198004. PubMed ID: 32380211
[TBL] [Abstract][Full Text] [Related]
7. Human Papillomavirus 16 Oncoprotein Expression Is Controlled by the Cellular Splicing Factor SRSF2 (SC35).
McFarlane M; MacDonald AI; Stevenson A; Graham SV
J Virol; 2015 May; 89(10):5276-87. PubMed ID: 25717103
[TBL] [Abstract][Full Text] [Related]
8. Human papillomavirus type 16 E2 and E6 are RNA-binding proteins and inhibit in vitro splicing of pre-mRNAs with suboptimal splice sites.
Bodaghi S; Jia R; Zheng ZM
Virology; 2009 Mar; 386(1):32-43. PubMed ID: 19187948
[TBL] [Abstract][Full Text] [Related]
9. hnRNP L controls HPV16 RNA polyadenylation and splicing in an Akt kinase-dependent manner.
Kajitani N; Glahder J; Wu C; Yu H; Nilsson K; Schwartz S
Nucleic Acids Res; 2017 Sep; 45(16):9654-9678. PubMed ID: 28934469
[TBL] [Abstract][Full Text] [Related]
10. Heterogeneous Nuclear Ribonucleoprotein C Proteins Interact with the Human Papillomavirus Type 16 (HPV16) Early 3'-Untranslated Region and Alleviate Suppression of HPV16 Late L1 mRNA Splicing.
Dhanjal S; Kajitani N; Glahder J; Mossberg AK; Johansson C; Schwartz S
J Biol Chem; 2015 May; 290(21):13354-71. PubMed ID: 25878250
[TBL] [Abstract][Full Text] [Related]
11. E6^E7, a novel splice isoform protein of human papillomavirus 16, stabilizes viral E6 and E7 oncoproteins via HSP90 and GRP78.
Ajiro M; Zheng ZM
mBio; 2015 Feb; 6(1):e02068-14. PubMed ID: 25691589
[TBL] [Abstract][Full Text] [Related]
12. The E7 oncoprotein is translated from spliced E6*I transcripts in high-risk human papillomavirus type 16- or type 18-positive cervical cancer cell lines via translation reinitiation.
Tang S; Tao M; McCoy JP; Zheng ZM
J Virol; 2006 May; 80(9):4249-63. PubMed ID: 16611884
[TBL] [Abstract][Full Text] [Related]
13. hnRNP G prevents inclusion on the HPV16 L1 mRNAs of the central exon between splice sites SA3358 and SD3632.
Yu H; Gong L; Wu C; Nilsson K; Li-Wang X; Schwartz S
J Gen Virol; 2018 Mar; 99(3):328-343. PubMed ID: 29458523
[TBL] [Abstract][Full Text] [Related]
14. [Effects of hnRNP E1 on expression of early genes E2, E6 of HPV16 and biological function in cervical cancer cells].
Song L; Ding L; Feng MJ; Li XX; Gao W; Qi Z; Liu H; Wang M; Wang JT
Zhonghua Liu Xing Bing Xue Za Zhi; 2021 Feb; 42(2):321-326. PubMed ID: 33626623
[No Abstract] [Full Text] [Related]
15. Overexpression of m6A-factors METTL3, ALKBH5, and YTHDC1 alters HPV16 mRNA splicing.
Cui X; Nilsson K; Kajitani N; Schwartz S
Virus Genes; 2022 Apr; 58(2):98-112. PubMed ID: 35190939
[TBL] [Abstract][Full Text] [Related]
16. Human papillomavirus type 31 replication modes during the early phases of the viral life cycle depend on transcriptional and posttranscriptional regulation of E1 and E2 expression.
Hubert WG; Laimins LA
J Virol; 2002 Mar; 76(5):2263-73. PubMed ID: 11836404
[TBL] [Abstract][Full Text] [Related]
17. Identification of an hnRNP A1-dependent splicing silencer in the human papillomavirus type 16 L1 coding region that prevents premature expression of the late L1 gene.
Zhao X; Rush M; Schwartz S
J Virol; 2004 Oct; 78(20):10888-905. PubMed ID: 15452209
[TBL] [Abstract][Full Text] [Related]
18. Influence of physiologic folate deficiency on human papillomavirus type 16 (HPV16)-harboring human keratinocytes in vitro and in vivo.
Xiao S; Tang YS; Khan RA; Zhang Y; Kusumanchi P; Stabler SP; Jayaram HN; Antony AC
J Biol Chem; 2012 Apr; 287(15):12559-77. PubMed ID: 22351779
[TBL] [Abstract][Full Text] [Related]
19. Human papillomavirus type 16 E6 and E7 oncoproteins interact with the nuclear p53-binding protein 1 in an in vitro reconstructed 3D epithelium: new insights for the virus-induced DNA damage response.
Squarzanti DF; Sorrentino R; Landini MM; Chiesa A; Pinato S; Rocchio F; Mattii M; Penengo L; Azzimonti B
Virol J; 2018 Nov; 15(1):176. PubMed ID: 30445982
[TBL] [Abstract][Full Text] [Related]
20. The full-length E6 protein of human papillomavirus type 16 has transforming and trans-activating activities and cooperates with E7 to immortalize keratinocytes in culture.
Sedman SA; Barbosa MS; Vass WC; Hubbert NL; Haas JA; Lowy DR; Schiller JT
J Virol; 1991 Sep; 65(9):4860-6. PubMed ID: 1651408
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
